ADMA Biologics (ADMA) P/E Ratio
P/E Ratio as of Jul 2, 2025: 21.49
Average23.00
Median23.00
Minimum20.85
Maximum25.91
21.49
Past Month-2.01 (8.55%)
The P/E ratio for ADMA Biologics (ADMA) is 21.49 as of Jul 2, 2025. This represents a decrease of -60.93% compared to its 12-month average P/E ratio of 55.01. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
ADMA Biologics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
ADMA Biologics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing ADMA Biologics to industry peers.
ADMA Biologics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
ADMA Biologics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing ADMA Biologics to industry peers.
ADMA Biologics (ADMA) P/E Ratio Insights
See ADMA Biologics’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in ADMA Biologics (ADMA)
Order type
Buy in
Order amount
Est. shares
0 shares
ADMA Biologics (ADMA) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jul 1, 2025 | $17.88 | 21.18 |
| Jun 2, 2025 | $20.43 | 24.20 |
| May 1, 2025 | $23.27 | 28.75 |
| Apr 1, 2025 | $19.42 | 23.99 |
| Mar 3, 2025 | $15.83 | 19.44 |
| Feb 3, 2025 | $16.47 | 59.61 |
| Jan 2, 2025 | $17.97 | 65.04 |
ADMA Biologics (ADMA) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | 21.49 | -65.38% |
| 2024 | 62.07 | -248.99% |
| 2023 | -41.66 | +292.65% |
| 2022 | -10.61 | +300.38% |
| 2021 | -2.65 | +20.45% |
| 2020 | -2.20 | — |
FAQs About ADMA Biologics (ADMA) P/E ratio
The latest P/E ratio of ADMA Biologics (ADMA) is 21.49, as of Jul 2, 2025. This is calculated based on its current stock price and earnings per share (EPS).
ADMA Biologics’s last 12-month average P/E ratio is 55.01, compared to its current P/E ratio of 21.49. This reflects a decrease of -60.93%.
ADMA Biologics’s current P/E ratio of 21.49 is lower than its last 12-month average P/E of 55.01. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
ADMA Biologics’s average P/E ratio over the last 3 years is -21.7. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
ADMA Biologics’s average P/E ratio over the last 5 years is -14.13. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.